News
Novus Therapeutics Reports First Quarter 2020 Financial Results
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced financial
Fuel Tech Reports 2020 First Quarter Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
Mannatech Reports First Quarter 2020 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2020.
Fuel Tech Announces FUEL CHEM® Demonstration Orders From Two New Industrial Power Customers
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
Fuel Tech Adjourns Annual Meeting of Stockholders to June 16, 2020
Fuel Tech, Inc. (NASDAQ: FTEK) (or “the Company”), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in
Phio Pharmaceuticals: Darum ist der Knall sicher!
Bei Phio Pharmaceuticals (WKN: A2PYB0) ist großes Spektakel am Köcheln. Der Micro Cap ist unser spekulativer Top-Tipp des laufenden Monats. Im Idealfall winkt ein Vervielfacher aus dem Stand.
Mit
Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Genprex Issues April 2020 Shareholder Letter
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced
Fuel Tech Schedules First Quarter 2020 Financial Results and Conference Call
Fuel Tech, Inc. (NASDAQ: FTEK) (or “the Company”), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in
Dover Motorsports, Inc. Reports Results for the First Quarter Ended March 31, 2020
Dover Motorsports, Inc. (NYSE: DVD) today reported its results for the three months ended March 31, 2020.
The Company historically reports a loss in the first quarter due to the seasonality of
AYRO Announces Third Quarter European Market Expansion with Strategic Partner Club Car
AYRO, Inc., (www.ayro.com) designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets, announces the
Dover Motorsports, Inc. Announces First Quarter 2020 Earnings Release Date
Dover Motorsports, Inc. (NYSE: DVD) will report its earnings for the first quarter ended March 31, 2020 on the morning of Thursday, April 30, 2020. Commentary from the Company’s executive officers
Genprex Appoints Shannon Inman as Vice President of Global Clinical Operations
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Dover Motorsports, Inc. Annual Meeting of Stockholders on April 29, 2020 Change in Meeting Location
Dover Motorsports, Inc. (NYSE: DVD) today announced that its Annual Meeting of Stockholders will be held as a virtual only meeting.
The meeting will still take place on April 29, 2020 at 9:00 AM
1347 Property Insurance Holdings, Inc. Reports Preliminary First Quarter 2020 Financial Information
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”), which intends to operate as a diversified holding company of reinsurance and investment management businesses, today announced
EKIMAS Corporation Announces Special Cash Distribution
EKIMAS Corporation (OTCQB: “ASNB”), formerly AdvanSource Biomaterials Corporation (the “Company”), which sold substantially all of its assets to Mitsubishi Chemical Performance Polymers, Inc. on
ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye Disease
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX), a clinical-stage biomedical company, having recently announced filing for patent protection for new
AYRO Along With Strategic Partner, Club Car, Expand Into Higher-Ed Market at Princeton and Penn State
AYRO, Inc., (ayro.com) designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets, announces the
Phio: Starke Krebs-Daten befeuern Deal-Phantasie!
Phio Pharmaceuticals (WKN: A2PYB0) liefert neue positive Studiendaten zu seiner Immuntherapie-Plattform INTASYL. Die weit unter Buchwert handelnde Aktie schießt in die Höhe.
Wie Phio heute
1347 Property Insurance Holdings, Inc. Reports Fiscal Year 2019 Financial Results; Provides Updates on Business Strategy and Corporate Name Change
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”), a holding company which previously specialized in providing personal property insurance in coastal markets including those in
Mannatech Reports Fourth Quarter 2019 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of
ProtoKinetix Ready to Ship AAGP® to the University of Alberta for the Continuation of Phase 1 Human Trials
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced an update to the Press Release of January 24,
Genprex Bolsters Board of Directors, Appoints Three Biotechnology and Healthcare Industry Leaders
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
Bango Quantifies Increases to “Stay at Home” Behavior
Bango (AIM: BGO), the mobile commerce company, has analyzed payment data from countries initially impacted by the outbreak of Covid-19. Data from Singapore, Taiwan, South Korea, Japan and Hong Kong